• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[半乳糖凝集素-3基因第98位密码子的多态性与甲状腺良恶性肿瘤无关]

[Polymorphism on codon 98 of the galectin-3 gene is not associated to benign and malignant thyroid tumors].

作者信息

Martins Luciane, Leoni Suzana Garcia, Friguglietti Celso U M, Ward Laura Sterian, Kulcsar Marco Aurélio V, Kimura Edna Teruko

机构信息

Departamento de Biologia Celular e do Desenvolvimento, Instituto de Ciências Biomédicas, Universidade de São Paulo.

出版信息

Arq Bras Endocrinol Metabol. 2006 Dec;50(6):1075-81. doi: 10.1590/s0004-27302006000600014.

DOI:10.1590/s0004-27302006000600014
PMID:17221114
Abstract

Galectin-3 is a multifunctional protein highly expressed in thyroid cancer. The galectin-3 gene (LGALS3) has several annotated candidates SNPs, however the relationship between galectin-3 SNPs and specific phenotypic variations relevant to health has not been evaluated. In this study, we investigated SNPs in the galectin-3 gene and a putative association with thyroid tumorigenesis. The presence of LGALS3 SNPs in thyroid carcinoma cell lines (NPA, TPC-1, WRO, ARO), thyroid tissues of 55 patients with multinodular goiter or papillary carcinoma diagnosis and lymphocytes of peripheral blood of 45 healthy individuals was evaluated by sequencing and SSCP. The analysis of LGALS3 coding sequence showed that the T98P site presents a great genotypic variation, since we observed both homozygous (AA or CC) and heterozygous (AC) patterns. In thyroid carcinoma cell lines, the genotype of NPA in the LGALS3 T98P site is CC, while TPC-1, WRO and ARO are AC. The genotypic frequency of T98P SNP observed in multinodular goiter (AC= 67%; AA= 23%; CC= 10%) and papillary carcinoma (AC= 68%; AA= 20%; CC= 12%) were similar to the frequency observed in the control population (AC= 60%, AA= 24%, CC= 16%). In conclusion, no association between LGALS3 T98P genotype and the phenotype of the benign or malignant thyroid tumor was observed.

摘要

半乳糖凝集素-3是一种在甲状腺癌中高表达的多功能蛋白质。半乳糖凝集素-3基因(LGALS3)有多个注释的候选单核苷酸多态性(SNP),然而,半乳糖凝集素-3的SNP与健康相关的特定表型变异之间的关系尚未得到评估。在本研究中,我们调查了半乳糖凝集素-3基因中的SNP及其与甲状腺肿瘤发生的潜在关联。通过测序和单链构象多态性(SSCP)评估了甲状腺癌细胞系(NPA、TPC-1、WRO、ARO)、55例诊断为多结节性甲状腺肿或乳头状癌患者的甲状腺组织以及45名健康个体外周血淋巴细胞中LGALS3 SNP的存在情况。LGALS3编码序列分析表明,T98P位点存在很大的基因型变异,因为我们观察到了纯合子(AA或CC)和杂合子(AC)模式。在甲状腺癌细胞系中,LGALS3 T98P位点NPA的基因型为CC,而TPC-1、WRO和ARO为AC。在多结节性甲状腺肿(AC = 67%;AA = 23%;CC = 10%)和乳头状癌(AC = 68%;AA = 20%;CC = 12%)中观察到的T98P SNP基因型频率与在对照人群中观察到的频率(AC = 60%,AA = 24%,CC = 16%)相似。总之,未观察到LGALS3 T98P基因型与良性或恶性甲状腺肿瘤表型之间存在关联。

相似文献

1
[Polymorphism on codon 98 of the galectin-3 gene is not associated to benign and malignant thyroid tumors].[半乳糖凝集素-3基因第98位密码子的多态性与甲状腺良恶性肿瘤无关]
Arq Bras Endocrinol Metabol. 2006 Dec;50(6):1075-81. doi: 10.1590/s0004-27302006000600014.
2
Pro64His (rs4644) Polymorphism Within Galectin-3 Is a Risk Factor of Differentiated Thyroid Carcinoma and Affects the Transcriptome of Thyrocytes Engineered via CRISPR/Cas9 System.半胱氨酸蛋白酶抑制剂 64 基因 Pro64His(rs4644) 多态性与甲状腺分化癌的相关性及其对 CRISPR/Cas9 系统构建甲状腺细胞系转录组的影响
Thyroid. 2021 Jul;31(7):1056-1066. doi: 10.1089/thy.2020.0366. Epub 2021 Mar 2.
3
Single Nucleotide Polymorphisms at +191 and +292 of Galectin-3 Gene (LGALS3) Related to Lower GAL-3 Serum Levels Are Associated with Frequent Respiratory Tract Infection and Vaso-Occlusive Crisis in Children with Sickle Cell Anemia.半乳糖凝集素-3基因(LGALS3)+191和+292位点的单核苷酸多态性与较低的GAL-3血清水平相关,这与镰状细胞贫血患儿频繁的呼吸道感染和血管闭塞性危象有关。
PLoS One. 2016 Sep 7;11(9):e0162297. doi: 10.1371/journal.pone.0162297. eCollection 2016.
4
Galectin-1 is a diagnostic marker involved in thyroid cancer progression.半乳糖凝集素-1 是一种参与甲状腺癌进展的诊断标志物。
Int J Oncol. 2017 Sep;51(3):760-770. doi: 10.3892/ijo.2017.4065. Epub 2017 Jul 4.
5
Ubiquitous expression of galectin-3 mRNA in benign and malignant thyroid tumors.半乳糖凝集素-3 mRNA在甲状腺良恶性肿瘤中的广泛表达。
Cancer Lett. 2003 Sep 10;199(1):69-73. doi: 10.1016/s0304-3835(03)00343-4.
6
VDR gene FokI polymorphism as a poor prognostic factor for papillary thyroid cancer.维生素D受体基因FokI多态性作为甲状腺乳头状癌的不良预后因素
Tumour Biol. 2018 Nov;40(11):1010428318811766. doi: 10.1177/1010428318811766.
7
Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer.上游转录因子1(USF1)单核苷酸多态性与甲状腺乳头状癌易感性的关联。
Clin Endocrinol (Oxf). 2016 Apr;84(4):564-70. doi: 10.1111/cen.12832. Epub 2015 Aug 14.
8
High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas.人低分化甲状腺癌中p53基因突变的高发生率。
J Clin Invest. 1993 Jan;91(1):179-84. doi: 10.1172/JCI116168.
9
GSTO polymorphism analysis in thyroid nodules suggest that GSTO1 variants do not influence the risk for malignancy.甲状腺结节中谷胱甘肽S-转移酶O(GSTO)多态性分析表明,GSTO1变异体不会影响恶性肿瘤风险。
Eur J Cancer Prev. 2005 Jun;14(3):277-80. doi: 10.1097/00008469-200506000-00013.
10
Galectin-3 maintains the transformed phenotype of thyroid papillary carcinoma cells.半乳糖凝集素-3维持甲状腺乳头状癌细胞的转化表型。
Int J Oncol. 2001 Apr;18(4):787-92. doi: 10.3892/ijo.18.4.787.

引用本文的文献

1
Galectin-3 Determines Tumor Cell Adaptive Strategies in Stressed Tumor Microenvironments.半乳糖凝集素-3决定应激肿瘤微环境中肿瘤细胞的适应性策略。
Front Oncol. 2016 May 23;6:127. doi: 10.3389/fonc.2016.00127. eCollection 2016.